- Report
- August 2025
- 150 Pages
Global
From €3402EUR$3,850USD£2,997GBP
- Report
- August 2025
- 150 Pages
Global
From €3402EUR$3,850USD£2,997GBP
- Report
- August 2025
- 150 Pages
Global
From €2519EUR$2,850USD£2,219GBP
€3402EUR$3,850USD£2,997GBP
- Report
- July 2025
- 150 Pages
Global
From €3402EUR$3,850USD£2,997GBP
€4286EUR$4,850USD£3,776GBP
- Report
- July 2025
- 150 Pages
Global
From €3402EUR$3,850USD£2,997GBP
€4286EUR$4,850USD£3,776GBP
- Report
- March 2025
- 150 Pages
Global
From €3402EUR$3,850USD£2,997GBP
€4286EUR$4,850USD£3,776GBP
- Report
- July 2025
- 350 Pages
Global
From €4373EUR$4,949USD£3,853GBP
- Report
- July 2025
- 350 Pages
Global
From €4373EUR$4,949USD£3,853GBP
- Report
- August 2025
- 145 Pages
Global
From €3491EUR$3,950USD£3,075GBP
- Report
- February 2025
- 148 Pages
Global
From €3491EUR$3,950USD£3,075GBP
- Report
- July 2025
- 363 Pages
Global
From €3932EUR$4,450USD£3,464GBP
- Report
- July 2025
- 220 Pages
Global
From €4414EUR$4,995USD£3,889GBP
- Report
- January 2025
- 220 Pages
Global
From €4414EUR$4,995USD£3,889GBP
- Report
- October 2025
- 112 Pages
Global
From €3500EUR$4,243USD£3,191GBP
- Report
- September 2025
- 99 Pages
Global
From €3500EUR$4,243USD£3,191GBP
- Report
- July 2025
- 94 Pages
Global
From €3500EUR$4,243USD£3,191GBP
- Report
- March 2025
- 96 Pages
Global
From €3500EUR$4,243USD£3,191GBP
- Report
- March 2025
- 110 Pages
Global
From €3500EUR$4,243USD£3,191GBP
- Report
- January 2025
- 89 Pages
Global
From €3500EUR$4,243USD£3,191GBP
- Report
- October 2025
- 160 Pages
Global
From €2967EUR$3,358USD£2,614GBP
€3491EUR$3,950USD£3,075GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more